Senior insider sale
President and Chairman at Y-MABS THERAPEUTICS, INC. — senior position signals high conviction
$1.23M
102.35K shares
What this filing means
GAD THOMAS plans to sell 102.35K shares of Y-MABS THERAPEUTICS, INC. valued at approximately $1.23M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/10/2024ACC: 0001968582-24-000477
DirectorOfficer· President and Chairman
Since Sep 2018
102.35K
Shares to sell
$1.23M
Approx. market value
70K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Private Investment
Cash
8/15/2015
70KTotal acquired70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/15/2015 | Private Investment Cash | 70K | — |
| Total | 70K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
7.35K
Market value
$94.1K
5/23/2024
—Completed
Units to sell
25K
Market value
$296.2K
5/21/2024
Planned — Approximate Date
NasdaqPlanned
Units to sell
70K
Market value
$838.6K
6/10/2024
Total
Units
102.35K
Value
$1.23M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/23/2024 | 7.35K | $94.1K | — | Completed |
5/21/2024 | 25K | $296.2K | — | Completed |
| Planned — Approximate Date | ||||
6/10/2024 | 70K | $838.6K | Nasdaq | Planned |
| Total | 102.35K | $1.23M | ||